Enjoy complimentary customisation on priority with our Enterprise License!
The prefilled syringes market size is forecast to increase by USD 4.04 billion at a CAGR of 9.45% between 2023 and 2028. The market is experiencing significant growth due to favorable regulations and guidelines encouraging the shift from glass to plastic pre-filled syringes. This transition is driven by the surge in demand for vaccinations, particularly in developing countries. Plastic pre-filled syringes offer numerous advantages, including improved safety, cost-effectiveness, and ease of use. Regulatory bodies, such as the FDA and EMA, have issued guidelines supporting the use of syringes made of plastic, citing their benefits in reducing the risk of glass breakage and needle-stick injuries. As a result, the market for pre-filled syringes is projected to expand at a robust rate, with manufacturers ramping up production to meet the increasing demand.
To learn more about this prefilled syringes market report, Download Report Sample
The market continues to evolve amidst growing concerns over chronic diseases and the safety of healthcare professionals. Needlestick legislation has become pivotal in safeguarding both patients and practitioners. With a surge in the use of biologics and biosimilars for treating autoimmune disorders and heart diseases, the demand for convenient self-injection devices is escalating. Understanding the prevalence of chronic disorders and their annual cost burden, stakeholders are seeking efficient drug candidates and reliable partner analysis.
Recent advancements include innovations in injectable medication packaging such as multi-chamber syringes and conventional vials. However, concerns linger over occasional product recalls and the need for enhanced lubrication technology for smoother injections. The introduction of the mRNA COVID-19 vaccine and other travel vaccines has further accelerated the adoption of prefilled syringes, along with a parallel demand for compatible saline syringes. As the market grows, emphasis on safety, efficacy, and user convenience remains paramount.
The shift from glass pre-filled syringes to plastic pre-filled syringes is the key factor driving the growth of the global pre-filled syringes market. Owing to the introduction of advanced polymer materials such as polypropylene and crystal-clear polymer plastic pre-filled syringes are becoming more popular, which are biocompatible with the other components of the syringe. Most pre-filled syringes currently attracting attention in the market which made of glass. Due to the inherent drawbacks of glass pre-filled syringes, such as being prone to breakage and drug interactions, over time manufacturers have switched to plastic as the preferred material for pre-filled syringes.
Moreover, the market is shifting toward plastic and disposable syringes, so the needle is protected and cannot be reused as part of pre-filled disposable systems. Advances in polymer technology have increased the use of plastic pre-filled syringes that overcome many of the limitations of glass prefilled syringes. Many companies in Europe and America are following a similar trend. Leading market players such as BD, TERUMO, and Gerresheimer have already included plastic pre-filled syringes in their portfolios. This is expected to boost the growth of the global pre-filled syringes market during the forecast period.
Innovations in pre-filled syringes is the key trend driving the growth of the global pre-filled syringes market. The pre-filled syringe companies offer integrated automatic needle shielding and syringes with retractable needles. Some specialist pre-filled syringe manufacturers have come up with dual and multi-chambered syringes for lyophilized drugs. Major pharmaceutical market players such as Pfizer (XYNTHA) and Takeda Pharmaceutical Company (Prolia) started packaging lyophilized drugs in dual/multi-chambered syringes.
Furthermore, the market also sees better production technology, such as automated machines that allow manufacturers to produce more than 10,000 pre-filled syringes at one time. Industry experts believe that despite the wide availability of prefilled syringe design options in the market, many therapeutic areas remain untapped. Which is expected to contribute to the growth of the global pre-filled syringes market during the forecast period.
Device limitations and drawbacks is the key challenges for the growth of the global pre-filled syringes market. Due to the direct contact of the drug with the primary packaging of the syringe for long durations the quality of the drug might be compromised when stored in the pre-filled syringes. The silicone oil used to lubricate the pre-filled syringes contributes to the optimal functioning of these syringes. Some manufactured drugs contain proteins or peptides that may interact with the glass surface of pre-filled syringes.
Moreover, tungsten residues in pre-filled syringes can also degrade biotech drugs. There have been many cases of pharmaceutical companies that provide drugs in pre-filled syringes recalling their products due to drug interactions. When air enters your blood vessels, it can block them and lead to serious health hazards such as stroke and death. Such factors are expected to impede the growth of the market in focus during the forecast period.
The market share growth by the Glass prefilled syringe segment will be significant during the forecast period. The segment is anticipated to significantly boost the market in focus because they are easier to regulate, more widely accepted by end users, and have a greater selection of medications than plastic. They are disposable needle systems containing pre-packaged pharmaceuticals or biologicals for injectables that are ready to use.
The Glass prefilled syringe segment was the largest and was valued at USD 3.82 billion in 2018. The focus on diabetes care addressing conditions like type 1 diabetes has spurred advancements in treatments and insulin delivery methods. The choice of route of administration within the segment has gained prominence due to its effectiveness and ease of use, contributing to diverse product portfolios. It is considered the gold standard, as the material has been popular in the pharmaceutical industry for decades compared with plastic.
North America is estimated to contribute 37% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional market growth and trends that shape the market during the forecast period.
To understand geographic trends, Download Report Sample
The market is experiencing significant growth in regions with high prevalence rates of chronic conditions, such as rheumatoid arthritis, cardiovascular disorders, and oncological disorders. According to the CDC, approximately 11.3% of the US population had diabetes in 2022. Technological advancements in self-administering devices like autoinjectors and pen injectors, as well as CDC recommendations, are driving market expansion. In the context of increasing healthcare costs, patient compliance, and convenient usage are crucial factors. Pre-filled syringes offer dose precision, reducing the risk of contamination and drug wastage.
The market is fragmented in nature. Some significant players include
ApiJect Systems Corp.: The company offers prefilled syringes such as Prefilled ApiJect Injector is the combination of two trusted technologies, the Blow Fill Seal aseptic drug packaging process, and a pen needle style needle hub.
The prefilled syringes research report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:
Ajinomoto Bio Pharma Services, ApiJect Systems Corp., AptarGroup Inc., Baxter International Inc., Becton Dickinson and Co., Catalent Inc., Fresenius SE and Co. KGaA, Gerresheimer AG, Haselmeier GmbH, Nipro Corp., Novartis AG, Owen Mumford Ltd., Recipharm AB, SCHOTT AG, SHL Medical AG, STERINOVA, Terumo Corp., Vetter Pharma Fertigung GmbH and Co. KG, Viatris Inc., and West Pharmaceutical Services Inc.
The prefilled syringes market research report provides comprehensive data (region wise segment analysis), with forecasts and estimates in "USD billion" for the period 2024-2028, as well as historical data from 2018 - 2022 for the following segments.
The prefilled syringes market is witnessing significant growth attributed to the rising concerns over needle stick injuries and blood-borne infections. With a notable increase in autoimmune diseases and cancer cases, there's a pressing need for safe and efficient drug delivery methods. Challenges like insufficient healthcare funding and medical inflation have prompted the exploration of cheaper alternatives and innovative delivery systems like oral drug delivery, inhalable insulin, and nasal drug delivery.
Safety remains paramount, driving the demand for safety prefilled syringes and flush syringes, especially in emergency situations such as anaphylactic shock. The aging geriatric population further accentuates the need for user-friendly self-injection devices and home care services. To address concerns about drug waste and optimize API use, manufacturers are focusing on compatibility with filling machines and single-chamber prefilled syringes. As global healthcare costs rise, the market continues to innovate, emphasizing both efficacy and cost-effectiveness for hospital pharmacies and healthcare providers alike.
|
Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
164 |
|
Base year |
2023 |
|
Historic period |
2018 - 2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 9.45% |
|
Market growth 2024-2028 |
USD 4.04 billion |
|
Market structure |
Fragmented |
|
YoY growth 2023-2024(%) |
8.42 |
|
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
|
Performing market contribution |
North America at 37% |
|
Key countries |
US, Canada, Germany, China, and UK |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
|
Key companies profiled |
Ajinomoto Bio Pharma Services, ApiJect Systems Corp., AptarGroup Inc., Baxter International Inc., Becton Dickinson and Co., Catalent Inc., Fresenius SE and Co. KGaA, Gerresheimer AG, Haselmeier GmbH, Nipro Corp., Novartis AG, Owen Mumford Ltd., Recipharm AB, SCHOTT AG, SHL Medical AG, STERINOVA, Terumo Corp., Vetter Pharma Fertigung GmbH and Co. KG, Viatris Inc., and West Pharmaceutical Services Inc. |
|
Market dynamics |
Parent market analysis, Market Forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for market forecast period |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this prefilled syringes market research report to meet your requirements.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Material
7 Market Segmentation by Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get the report (PDF) sent to your email within minutes.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
